Medeon Biodesign, Inc.(TW:6499)
NT$75.80+2.80 (+6.91%)
TW:6499
Medeon Biodesign, Inc. Revenue
NT$75.80
At close:+2.80 (+6.91%)
Medeon Biodesign, Inc. (6499) Revenue
Medeon Biodesign, Inc. Revenue
Medeon Biodesign, Inc. had a revenue of 106.61M in the quarter ending Jun 30, 2026, with -6.72%. This bring the company's revenue in the last twelve months to 428.06M, Decreased 0.87%. In the fiscal year ending Dec 31, 2025, Medeon Biodesign, Inc. had annual revenue of 419.43M with 43.24% growth.
- Revenue (ttm)
- 428.06M
- Revenue Growth
- 69.62%
- P/S Ratio
- 17.47
- Revenue/Employee
- TWD 280,364
- Employees
- 1,496
- Market Cap
- TWD 7.33B
Revenue Chart
Medeon Biodesign, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 419.43M | 126.62M | 43.24% |
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | 123.06M | -330.71M | -72.88% |
| Dec 31, 2019 | 453.76M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.